United Therapeutics Corporation (NASDAQ: UTHR ) is at the forefront of innovation in the biotechnology and pharmaceutical industry. Its portfolio of FDA-approved products treats pulmonary arterial hypertension (PAH) and related cardiovascular conditions. The company's wide treatment options, including oral and injectable therapies like Orenitram, Remodulin, and Adcirca, strengthenMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politec ...